[1]
“A Prospective Study Analyzing Short Term Effects of Intravitreal versus Intracameral Bevacizumab on Neovascular Glaucoma”, mfm, vol. 28, no. 4, May 2024, Accessed: Jan. 31, 2026. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/3985